A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Letrozole|DRUG: Fluorouracil|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University